Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lief Therapeutics Launches Lief Rx, World's First Smart Patch for Mental Health, Now Covered By Insurance

Lief Rx's insurance covered wearable smart patch addresses the growing need for cost efficient, clinically effective, scalable mental health care services, where patients can access tools that help them understand and manage their mental health with the support of a healthcare provider, no matter where they are.


News provided by

Lief Therapeutics

Jan 21, 2020, 11:00 ET

Share this article

Share toX

Share this article

Share toX

Comfortable, discreet wearable for mental health
Comfortable, discreet wearable for mental health

SAN FRANCISCO, Jan. 21, 2020 /PRNewswire-PRWeb/ -- Lief Therapeutics announces Lief Rx, the world's first smart patch for mental health, is now covered by most U.S. insurance plans. Lief Rx is a clinical-grade ECG, discreetly worn under the user's clothing, that trains users to improve their heart rate variability (HRV), the emerging gold standard biomarker for mental health.

Lief Rx's clinical trial found that over 90% of study participants using Lief reported significantly reduced anxiety levels over the course of eight weeks. Participants were also able to significantly increase their HRV 10 points, or almost 50%, in 3 minute exercises with the device. Dr. Nolan Williams, Director of Interventional Psychiatry Clinical Research at Stanford University, explains "As a mental health biomarker, HRV is extremely promising, and Lief has designed a device to both measure and improve it. Lief's approach to tracking and improving HRV may be useful across a wide variety of mental health conditions." Healthcare providers can now offer Lief Rx, an FDA class II device, as an affordable non-pharmaceutical intervention for improving patient mental health.

“Lief gives patients a simple training tool to increase their resilience to mental health challenges. Our mission is to empower millions of people to improve their mental health with a safe and affordable alternative to pharmaceutical drugs.” -Rohan Dixit, CEO & Founder of Lief

Post this

While more than 40 million Americans suffer from anxiety or depression, many are not aware of how their HRV can exacerbate mental health symptoms. Lief Rx not only detects low HRV levels in real time, but helps users improve it through patented, haptic training exercises known as heart rate variability biofeedback (HRVB). Widely cited meta-analyses have found HRVB technology has stronger effects on symptoms of anxiety (ES = 0.83) than either cognitive behavioral therapy (ES = 0.70) or pharmaceuticals (ES = 0.60). Lief Therapeutics C.E.O., Rohan Dixit, shares "Lief gives patients a simple training tool to increase their resilience to mental health challenges. Our mission is to empower millions of people to improve their mental health with a safe and affordable alternative to pharmaceutical drugs."

Low HRV is a clear indicator of heightened stress, which is an underlying factor in up to 90% of all physician visits. In addition to being associated with stress, anxiety, depression, addiction, and PTSD, low HRV is associated with numerous other disease states, like cancer, diabetes, heart disease, obesity, erectile dysfunction, and more. Dr. Ty Canning, a Bay Area clinical psychologist with expertise in mindfulness-based interventions notes, "Lief Rx's approach to HRVB training gives prescriptive power to something as core to wellness as breathing. Without non-pharmaceutical anxiety management tools like Lief Rx, patients are left relying on addictive prescription drugs that may be helpful momentarily, but can ultimately hinder progress."

In addition to helping patients harness the power of their breath to improve their HRV levels in real-time, Lief Rx's clinician dashboard enables healthcare providers to monitor patients' biomarker data and send clinically validated psychological assessments directly to patients through the Lief Rx mobile app. Lief Rx gives healthcare providers access to patients' biomarker data in conjunction with their self report, thus enabling more accurate assessments of patients' mental health than ever before.

Lief Therapeutics is currently offering a one month free promotion for healthcare providers interested in using Lief Rx with their patients. Providers may visit getlief.com/healthcare_provider to sign up. Patients can reach out for assistance in determining eligibility for Lief Rx by visiting getlief.com or emailing [email protected].

About Lief Therapeutics
Lief Therapeutics offers biofeedback wearables for mental health to consumers and patients, as well as a remote patient monitoring platform for healthcare providers. Lief Rx, Lief's prescription-only device for patients, is indicated for HRV-based relaxation training and muscle re-education, which, as part of a healthy lifestyle, may help reduce the risk of anxiety and depression. For more information, visit http://www.getlief.com.

SOURCE Lief Therapeutics

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.